ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

25,892Medicare Part D Prescriptions Filled, Including Refills

Rank: 18 out of 1121

$1.07M Total Retail Price of All Prescriptions

Rank: 56 out of 1121

642 Patients Receiving at Least One Drug in Part D
76%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Tennessee
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 642 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

23% of this provider’s 642 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

3% of this provider’s 19,949 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$41 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

40 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Tennessee
FUROSEMIDE 935 823 1 7
OMEPRAZOLE 926 667 2 6
HYDROCODONE-ACETAMINOPHEN 864 551 S3 3 3
LISINOPRIL 724 521 4 4
LEVOTHYROXINE SODIUM 697 544 5 2
LOVASTATIN 590 464 6 26
SIMVASTATIN 564 434 7 1
METFORMIN HCL 544 362 8 8
CITALOPRAM HBR 512 413 9 18
POTASSIUM CHLORIDE 501 435 10 12
TRAMADOL HCL 491 336 11 25
METOPROLOL TARTRATE 474 374 12 9
GABAPENTIN 437 357 13 13
AMLODIPINE BESYLATE 422 365 14 5
MELOXICAM 422 328 14 22
ZOLPIDEM TARTRATE 360 277 16 19
WARFARIN SODIUM 335 297 17 11
GLYBURIDE 301 206 R 18 51
CLOPIDOGREL 265 246 19 27
DONEPEZIL HCL 257 254 20 35
PLAVIX 256 221 21 42
TRAZODONE HCL 255 167 22 40
CARVEDILOL 252 204 23 20
NAMENDA 241 241 24 53
PANTOPRAZOLE SODIUM 226 192 25 29
CLONIDINE HCL 219 174 26 39
MIRTAZAPINE 217 205 27 56
ISOSORBIDE MONONITRATE ER 210 182 28 62
TAMSULOSIN HCL 210 186 28 32
METOPROLOL SUCCINATE 205 177 30 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 198 144 31 31
CYMBALTA 189 100 32 50
HYDROCHLOROTHIAZIDE 179 122 33 10
AMOX TR-POTASSIUM CLAVULANATE 178 117 34 101
RANITIDINE HCL 175 102 35 33
PROMETHAZINE HCL 168 96 R 36 67
DIGOXIN 167 167 37 59
ESCITALOPRAM OXALATE 164 141 38 94
RISPERIDONE 158 117 39 82
ATORVASTATIN CALCIUM 157 138 40 15
ALLOPURINOL 156 113 41 30
ALENDRONATE SODIUM 150 147 42 37
LOSARTAN POTASSIUM 149 129 43 17
LEVOFLOXACIN 149 121 43 79
TRIAMTERENE-HCTZ 149 115 43 38
CYCLOBENZAPRINE HCL 146 77 R 46 83
LANTUS 128 118 47 52
DILTIAZEM 24HR CD 126 121 48 99
SULFAMETHOXAZOLE-TRIMETHOPRIM 123 89 49 108
NEXIUM 116 99 50 24
ATENOLOL 116 92 50 16
LEXAPRO 114 107 52 218
BACLOFEN 111 49 53 131
VENLAFAXINE HCL ER 111 78 53 113
HYDRALAZINE HCL 110 100 55 66
KLOR-CON 10 110 102 55 69
CARBAMAZEPINE 107 51 57 203
ALBUTEROL SULFATE 105 100 58 141
LANSOPRAZOLE 104 79 59 162
PRAVASTATIN SODIUM 101 98 60 14
LOSARTAN-HYDROCHLOROTHIAZIDE 100 100 61 46
PAROXETINE HCL 100 47 61 58
MORPHINE SULFATE ER 99 31 S2 63 87
ROPINIROLE HCL 99 63 63 91
OXYBUTYNIN CHLORIDE 99 88 63 128
GALANTAMINE HBR 94 94 66 243
FLUCONAZOLE 94 57 66 156
TIZANIDINE HCL 92 66 68 124
BENAZEPRIL HCL 90 62 69 41
CAPTOPRIL 90 65 69 293
GLIMEPIRIDE 88 64 71 34
ADVAIR DISKUS 86 73 72 64
FINASTERIDE 84 84 73 117
SINGULAIR 82 32 74 78
FLUOXETINE HCL 80 19 75 60
VERAPAMIL ER 80 60 75 89
OXYCODONE-ACETAMINOPHEN 78 31 S2 77 122
CIPROFLOXACIN HCL 78 66 77 57
HUMULIN 70-30 76 52 79 244
SEROQUEL 76 66 79 134
METOCLOPRAMIDE HCL 75 43 81 120
PROAIR HFA 75 60 81 48
KLOR-CON M10 74 52 83 171
NIFEDIPINE ER 71 57 84 102
JANTOVEN 70 70 85 146
PREDNISONE 70 62 85 43
DILTIAZEM ER 69 69 87 105
VENTOLIN HFA 69 43 87 92
ZETIA 69 69 87 80
AMITRIPTYLINE HCL 68 63 R 90 61
QUETIAPINE FUMARATE 68 53 90 75
PHENYTOIN SODIUM EXTENDED 67 35 92 135
SPIRONOLACTONE 67 57 92 54
CARBIDOPA-LEVODOPA 66 66 94 118
NITROFURANTOIN MONO-MACRO 66 64 94 257
CARISOPRODOL 65 0 R 96 72
CRESTOR 65 53 96 28
FLUTICASONE PROPIONATE 64 45 98 36
BENZTROPINE MESYLATE 63 27 R 99 224
DIOVAN HCT 63 54 99 90
SERTRALINE HCL 62 49 101 21
AMIODARONE HCL 62 62 101 188
TERAZOSIN HCL 62 47 101 130
GLIPIZIDE 60 52 104 84
POLYETHYLENE GLYCOL 3350 59 54 105 70
FAMOTIDINE 58 49 106 63
MEGESTROL ACETATE 58 47 R 106 185
LUNESTA 57 48 108 288
ENALAPRIL MALEATE 56 41 109 73
HUMULIN R 56 46 109 227
ISOSORBIDE DINITRATE 54 54 111 192
PREMARIN 53 47 R 112 96
INSULIN SYRINGE 53 32 112 77
DIOVAN 53 51 112 45
METFORMIN HCL ER 52 48 115 47
GEMFIBROZIL 52 32 115 88
RAMIPRIL 52 52 115 74
NYSTATIN 51 31 118 147
NOVOLIN R 50 32 119 174
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 29, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.